Caldwell Trust’s Prothena Corp PRTA Stock Holding History

Caldwell Trust’s Portfolio PRTA Stock Details PRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-51	Closed	-$1.26K	–	715
2024 Q1	$1.26K	Buy	+51	New	+$1.52K	﹤0.01%	691

Other funds holding PRTA

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Caldwell Trust's PRTA Position: Q2 2024 in Review

Caldwell Trust sold out of Prothena Corp (PRTA) in Q2 2024, closing a stake of 51 shares — an estimated $1.26K sold.

Caldwell Trust first reported a position in PRTA in Q1 2024 and held it in 1 quarter. The position peaked at $1.26K in Q1 2024. 160 funds tracked by Wall St. Rank hold PRTA as of Q2 2024.

Caldwell Trust reported no remaining Prothena Corp position as of Q2 2024 after selling out during the quarter.
Caldwell Trust sold 51 Prothena Corp shares in Q2 2024, an estimated $1.26K.
Caldwell Trust first reported a position in Prothena Corp in Q1 2024 and held it in 1 quarter.
Caldwell Trust's Prothena Corp position peaked at $1.26K in Q1 2024.
160 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2024.

Based on Caldwell Trust's 13F filing for Q2 2024, filed 24 Sep 2025.